(Q46416781)

22 December 2017

title

Bendamustine, but not fludarabine, exhibits a low stem cell toxicity in vitro (English)

1 reference

22 December 2017

1 reference

M Schmidt-Hieber

1

1 reference

22 December 2017

A Busse

2

1 reference

22 December 2017

B Reufi

3

1 reference

22 December 2017

W Knauf

4

1 reference

22 December 2017

E Thiel

5

1 reference

22 December 2017

I W Blau

6

1 reference

22 December 2017

publication date

22 August 2008

1 reference

22 December 2017

Journal of Cancer Research and Clinical Oncology

published in

1 reference

22 December 2017

volume

135

1 reference

22 December 2017

issue

2

1 reference

22 December 2017

page(s)

227-234

1 reference

22 December 2017

https://scigraph.springernature.com/pub.10.1007/s00432-008-0453-8

exact match

0 references

cites work

A mathematical approach to study combined effects of toxicants in vitro: evaluation of the Bliss independence criterion and the Loewe additivity model.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-008-0453-8

In vitro toxicity of three new antitumoral drugs (trabectedin, aplidin, and kahalalide F) on hematopoietic progenitors and stem cells

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-008-0453-8

Myeloid clonogenic assays for comparison of the in vitro toxicity of alkylating agents

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-008-0453-8

Pharmacokinetic study of single doses of oral fludarabine phosphate in patients with "low-grade" non-Hodgkin's lymphoma and B-cell chronic lymphocytic leukemia

21 January 2018

1 reference

12 December 2020

Fludarabine. An update of its pharmacology and use in the treatment of haematological malignancies.

1 reference

12 December 2020

A phase I study of bendamustine hydrochloride administered day 1+2 every 3 weeks in patients with solid tumours

1 reference

12 December 2020

Predictive factors for a successful mobilization of peripheral blood CD34+ cells in multiple myeloma

1 reference

12 December 2020

Hematopoietic stem cell mobilization with intravenous melphalan and G-CSF in patients with chemoresponsive multiple myeloma: report of a phase II trial

1 reference

12 December 2020

Role of fludarabine in hematological malignancies

1 reference

12 December 2020

Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myeloma.

1 reference

12 December 2020

Late activation of apoptotic pathways plays a negligible role in mediating the cytotoxic effects of discodermolide and epothilone B in non-small cell lung cancer cells.

1 reference

12 December 2020

Cellular pharmacology of fludarabine triphosphate in chronic lymphocytic leukemia cells during fludarabine therapy

1 reference

12 December 2020

Prospective strategies to enforce selectively cell death in cancer cells

1 reference

12 December 2020

[The pharmacokinetics of bendamustine (Cytostasane) in humans]

1 reference

12 December 2020

Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent

1 reference

12 December 2020

In vitro studies with bendamustine: enhanced activity in combination with rituximab

1 reference

12 December 2020

Bendamustine in the treatment of hematologic malignancies. Introduction

1 reference

12 December 2020

Fludarabine and bendamustine in refractory and relapsed indolent lymphoma--a multicenter phase I/II Trial of the east german society of hematology and oncology (OSHO).

1 reference

12 December 2020

Treatment of bendamustine and prednisone in patients with newly diagnosed multiple myeloma results in superior complete response rate, prolonged time to treatment failure and improved quality of life compared to treatment with melphalan and predniso

1 reference

12 December 2020

Phase I studies with bendamustine: an update

1 reference

12 December 2020

1 reference

12 December 2020

Effects of amifostine on clonogenic mesenchymal progenitors and hematopoietic progenitors exposed to radiation

1 reference

12 December 2020

Lymphomas are sensitive to perforin-dependent cytotoxic pathways despite expression of PI-9 and overexpression of bcl-2

1 reference

12 December 2020

Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells

1 reference

12 December 2020

Phase III Intergroup Study of Fludarabine Phosphate Compared With Cyclophosphamide, Vincristine, and Prednisone Chemotherapy in Newly Diagnosed Patients With Stage III and IV Low-Grade Malignant Non-Hodgkin's Lymphoma

1 reference

12 December 2020

Impact of frontline fludarabine and cyclophosphamide combined treatment on peripheral blood stem cell mobilization in B-cell chronic lymphocytic leukemia

1 reference

12 December 2020

Cellular and clinical pharmacology of fludarabine

1 reference

12 December 2020

In vitro induction of apoptosis of neoplastic cells in low-grade non-Hodgkin's lymphomas using combinations of established cytotoxic drugs with bendamustine

1 reference

12 December 2020

In vitro evaluation of bendamustine induced apoptosis in B-chronic lymphocytic leukemia

1 reference

12 December 2020

Tumor cell senescence in cancer treatment

1 reference

12 December 2020

Bendamustine prolongs progression-free survival in metastatic breast cancer (MBC): a phase III prospective, randomized, multicenter trial of bendamustine hydrochloride, methotrexate and 5-fluorouracil (BMF) versus cyclophosphamide, methotrexate and

1 reference

12 December 2020

Blood stem cell mobilization and collection in patients with chronic lymphocytic leukaemia: a nationwide analysis.

1 reference

12 December 2020

Randomized trial of fludarabine versus fludarabine and idarubicin as frontline treatment in patients with indolent or mantle-cell lymphoma

1 reference

12 December 2020

Metabolism and mechanisms of action of bendamustine: rationales for combination therapies

1 reference

12 December 2020

10.1007/S00432-008-0453-8

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017